Japan's Ministry of Health, Labor and Welfare approved Shionogi new crown oral drug EUA
On November 22, Japan's Ministry of Health, Labor and Welfare approved Shionogi new crown oral drug EUA.
Previously, on September 28, Shionogi announced that the Phase III portion of a Phase II/III clinical trial of the 3CL protein inhibitor Ensitrelvir Fumaric Acid (S-217622) in Asia met the primary endpoint.
The results showed that, for the first time, ensitrelvir was shown to significantly reduce the time to remission of the five typical symptoms of Omicron compared to placebo. At the same time, ensitrelvir also showed a significant reduction in viral RNA load on day 4 (after the third dose).

This is the second 3CL drug after Pfizer paxlovid. The difference is that paxlovid needs to be used in combination with ritonavir. Enstirelvir alone can be effective.
2026-10-12
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Brazil Confirms 32 Methanol Poisoning Cases Linked to Contaminated Alcoholic Beverages
-
US Tariff Refunds Could Reshape Seafood Trade
-
Hormuz Closure Raises Cold-Chain Risk
-
India Accuses Balaji Amines of Manufacturing Pharma-Grade Propylene Glycol Without Drug Manufacturing Licence
-
EU Officially Approves Rapeseed Oil as a Low-Risk Active Substance Until 2040
-
EFSA Unable to Confirm Safety of Fusarium flavolapis Fungal Protein as a Novel Food
-
EFSA Confirms Safety of β-Amylase Produced from Barley for Food Manufacturing Use
-
A White Storm Sweeps Through “Golden October”: China’s Titanium Dioxide Giants Join Forces in a Battle for SurvivalA White Storm Sweeps Through “Golden October”: China’s Titanium Dioxide Giants Join Forces in a Battle for Survival
-
J&J to Spin Off Orthopedics Business, Raises 2025 Forecast
-
Aspen Secures Approval to Market Lilly’s Mounjaro for Weight Loss in South Africa
Recommend Reading
-
Middle East Conflict Hits China Seafood Trade
-
Hormuz Closure Raises Cold-Chain Risk
-
EFSA Evaluates Extended Use of Pasteurised Akkermansia muciniphila as a Novel Food
-
Invista Reshuffles Global Nylon 66 Map: Shutting US and UK Plants, Betting Big on China—What Exactly Are They Aiming For?
-
Hormuz Sees at Least 12 Vessel Incidents in One Week as Traffic Falls to Two-Month Low
-
Four Chinese Industrial Giants Compete for Wodgina Lithium Mine
-
Business Society’s Market Outlook for Lithium Carbonate on August 25, 2026: Volatile
-
Business Society’s Market Outlook for Epoxy Resins on August 25, 2026: Stable
-
Business Society’s Market Outlook for Acrylic Acid on August 26, 2026: Clearly Upward Trend
-
Recent Acetic Acid Market Trends Show Strong Upward Momentum in China